UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV
- 1 November 2016
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 123 (11) , 2386-2392
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab InjectionsOphthalmology, 2014
- Impact of Availability of Anti–Vascular Endothelial Growth Factor Therapy on Visual Impairment and Blindness Due to Neovascular Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2012
- Visual impairment certification secondary to ARMD in Leeds, 2005–2010: is the incidence falling?Eye, 2012
- Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010American Journal of Ophthalmology, 2012
- Time Trends in the Incidence and Causes of Blindness in IsraelAmerican Journal of Ophthalmology, 2012
- Causes of blind certifications in England and Wales: April 1999–March 2000Eye, 2007
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .JAMA, 2004
- Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adultsOphthalmology, 2004